The role of biomarkers in personalized immunotherapy

BACKGROUND: Immune checkpoint inhibitors have revolutionized cancer therapeutic paradigm and substantially improved the survival of patients with advanced malignancies. However, a significant limitation is the wide variability in clinical response. MAIN TEXT: Several biomarkers have been evaluated i...

Descripción completa

Detalles Bibliográficos
Autores principales: Sankar, Kamya, Ye, Jing Christine, Li, Zihai, Zheng, Lei, Song, Wenru, Hu-Lieskovan, Siwen
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9118650/
https://www.ncbi.nlm.nih.gov/pubmed/35585623
http://dx.doi.org/10.1186/s40364-022-00378-0

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9118650/
https://www.ncbi.nlm.nih.gov/pubmed/35585623
http://dx.doi.org/10.1186/s40364-022-00378-0

Ejemplares similares